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Abstract: Research on the potential protective effects of coffee and its bioactives (caffeine,
chlorogenic acids and diterpenes) against oxidative stress and related chronic disease risk has been
increasing in the last years. The present review summarizes the main findings on the effect of coffee
consumption on protection against lipid, protein and DNA damage, as well as on the modulation of
antioxidant capacity and antioxidant enzymes in human studies. Twenty-six dietary intervention
studies (involving acute and chronic coffee intake) have been considered. Overall, the results
suggest that coffee consumption can increase glutathione levels and improve protection against
DNA damage, especially following regular/repeated intake. On the contrary, the effects of coffee
on plasma antioxidant capacity and antioxidant enzymes, as well as on protein and lipid damage,
are unclear following both acute and chronic exposure. The high heterogeneity in terms of type
of coffee, doses and duration of the studies, the lack of information on coffee and/or brew
bioactive composition, as well as the choice of biomarkers and the methods used for their evaluation,
may partially explain the variability observed among findings. More robust and well-controlled
intervention studies are necessary for a thorough understanding of the effect of coffee on oxidative
stress markers in humans.
Keywords: coffee; phenols; DNA damage; lipid damage; protein damage; antioxidant capacity;
antioxidant enzymes
1. Introduction
Coffee is one of the world’s most commonly consumed beverages, just after water and tea,
probably thanks to its aromatic bouquet and its stimulating effect on the central nervous system. In 2014,
coffee consumption has been estimated to reach over 50 million cups worldwide, with the highest
annual consumption registered in Finland, Norway and Denmark (11.4, 8.7 and 8.0 kg per capita,
respectively) [1], while per capita consumption for Italy and France was estimated in 5.6 kg and 5.4 kg,
respectively [2].
Coffee is made by grinding roasted coffee beans, representing the fruit of the coffee plant,
belonging to the Rubiaceae family. The main two species are Coffea arabica L. and Coffea canephora,
originated in Ethiopia and in tropical Africa, respectively. These two species are traditionally used
for making Arabica and Robusta coffees, with the former representing the most diffused species
worldwide [1]. Even if all coffee brews could be prepared with hot water and ground coffee
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beans, coffee can assume a number of different forms. In Italian bars, for example, coffee is usually
consumed as “espresso”, prepared by extracting finely ground powder with high-pressure hot water
to produce a 30 mL serving brew. At home, coffee is instead mainly prepared with a three-part
coffee-maker (called moka), in which hot water is forced up through the coffee to the top of the
machine. Further options include the French press, the American-style (drip) coffee, and many others.
The use of coffee in relation to its effects on health dates back many centuries, although the
first studies are linked with the Scientific Revolution. Despite the fact the association between coffee
and health has been explored for many decades, the actual role of coffee drinking has been long
debated, mainly because some potential negative aspects have been hypothesized. In the nineteenth
century, a moderate coffee consumption was considered helpful in reducing fatigue and improving
intellectual functions, but overconsumption could move coffee from food to poison. In the 1991,
the International Agency for Research on Cancer (IARC) classified coffee as “possibly carcinogenic to
humans“ because of a weak positive relationship between coffee consumption and the occurrence of
bladder, pancreatic and ovarian cancer [3]. Recently, an international Working Group of scientists from
IARC declared inadequate the evidence for the carcinogenicity of coffee drinking overall [4].
Independently from these controversies, coffee has been described as probably the most relevant
source of dietary antioxidant compounds [5], which are thought to counteract the action of reactive
oxygen species (ROS), the main contributors to the development of oxidative stress. Oxidative stress
occurs when the cellular production of oxidant molecules exceeds the availability of antioxidants able
to defeat these insults. Antioxidant-rich foods, like coffee, can therefore play an important role against
this condition through the scavenging of free radicals.
Coffee contains large amounts of bioactive compounds including caffeine, phenolic compounds,
trigonelline, diterpenes and soluble fiber [6]. Caffeine, representing the most widely studied
psychoactive molecule in history, is a methylxanthine partially responsible of the bitter characteristics of
coffee. The caffeine content in coffee may be affected by genetic and environmental factors, for instance
C. canephora has double the content of C. arabica (1.5–2.5 g and 0.9–1.3 g/100 g dry matter in green
seeds, respectively) [6]. The content of caffeine in a serving is also highly variable, depending on the
type of roasting (e.g., light, medium or dark), coffee-making method, and extraction (e.g., regular or
over extraction), with values ranging from 50 up to over 300 mg per cup [7]. Once ingested, caffeine is
rapidly absorbed in the upper gastrointestinal tract, with a peak value within 60 min of ingestion [8].
The intake of caffeine has been associated with a high number of biological effects, mainly concerning
the stimulation of the central and sympathetic nervous system, typically associated to a feeling of
alertness after coffee consumption [9–12]. Recently, the intake of caffeine has been also reported to
exert ergogenic effects, as in 2011, the request of a health claim for caffeine in this direction has received
a positive opinion from the European Food Safety Authority (EFSA) [13].
Regarding diterpenes, coffee contains cafestol and kahweol, which have been found in higher
amount (up to 1.2 g/100 g dry matter) in C. arabica seeds. Being poorly soluble in water,
these compounds can be trapped by filters so they are present mainly in unfiltered coffee, as well as
in espresso. In spite of the anticarcinogenic and hepatoprotective properties that have been reported
in in vitro and animal models, a high intake of cafestol and kahweol seems to increase the risk of
CHD, mainly through an increase of plasma LDL. A meta-analysis on 11 trials showed an increase of
5.0 mg/dL and 0.9 mg/dL in serum total cholesterol with each 10 mg of cafestol or kahweol consumed
per day for four weeks, respectively, with a linear effect up to 100 mg of cafestol/day [14].
Among phenolic compounds, chlorogenic acids (CGAs) are the most abundant in coffee,
representing more than 98% of its total phenolic content, as shown in Figure 1, while the remaining 2%
is composed of alkylmethoxyphenols, alkylphenols, methoxyphenols, and other phenolics such as
pyrogallol, catechol, and phenol [15].
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CGAs are a group of esters formed by hydroxycinnamic acids, such as caffeic acid, ferulic acid
and p-coumaric acid, bound to quinic acid in a range of conjugated structures known as caffeoylquinic
acids, feruloylquinic aci s, and p-coumaroylquinic acids [16]. The isomers of these compounds depend
on the sit of est ification th t can occur at positi ns 1, 3, 4 or 5 of the quinic acid moiety [17]. The most
abundant and most tudie CGA is 5-caffeoylquinic acid (5-CQA), accounting for about 50% of the
total content in green coffee beans [15]. As reported for caffeine and diterpenes, the content of CGAs
in coffee may vary depending on several factors. For example, genetics has been shown to deeply
influence both the occurrence of CGAs, with C. robusta generally displaying a higher CGA content than
C. arabica [18,19], and the proportion of individual CGA subgroups. Environmental factors, like rainfall
level and different mean temperatures, have been reported to affect coffee CGA content even in the
same cultivar grown in the same growing area over different years [20].
As regards th processing of coffee, r asting appears to be a critical process for th evolution of
flavor, roma and color in traditi nal coffee beverages as well as for their CGA cont nt, with a rel vant
loss of CQAs (up to 90%) in dark roaste beans compared to unroasted gre n beans. In ddition,
CGA levels may be affected by the brewing method so that an over-extraction (~55 mL) has been
reported to increase over 85% the total CGAs with respect to the regular extraction (~23 mL) [7].
However, CGAs are generally preserved during coffee brewing, resulting in a final concentration that
could be higher than 150 mg per serving [7]. Therefore, in spite of the huge CGA loss during roasting
and the differences among preparations, coffee still remains the major dietary source of CGAs, to a
level that regular coffee intake by heavy drinkers may lead to a daily intake higher that 1 g.
Despite the high amounts of ingested CGAs, only low concentrations of chlorogenic acids in their
native forms have been found in blood, and extensive metabolic transformations were previously
described [21]. Actually, if an extremely low amount of these compounds is absorbed in the small
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intestine, most of CGAs reach the colon, where they can be metabolized by the local microbiota.
Metabolites are then absorbed, further conjugated in the liver, and distributed to the tissues [17].
At least ten conjugates, dihydroisoferulic acid 3-O-glucuronide, caffeic acid 3-sulfate, as well as the
sulfate and glucuronide derivatives of 3,4-dihydroxyphenylpropionic acid, were identified in human
plasma and/or urine after coffee consumption [22].
2. Objective and Literature Search Strategy
The present review aims to summarize the main findings of human intervention studies
investigating the effects of coffee consumption on oxidative stress. In detail, the effects of coffee
consumption on markers of lipid, protein and DNA damage, as well as on markers related to
antioxidant capacity and antioxidant enzymes, are reviewed. Most of these markers are considered
sensitive and specific biomarkers for antioxidant status and can be useful for a better comprehension
of the role of antioxidant-rich foods, including coffee, against oxidative stress and related conditions.
PUBMED, Web of Science and Scopus databases were searched to identify pertinent articles.
The searches used the combination of the following terms: “coffee”, “antioxidant capacity”,
“antioxidant activity”, “DNA damage”, “protein damage”, “lipid damage”, “oxidation” and “human”.
Reference lists of the retrieved papers were also searched for additional articles. The search strategy is
summarized in Figure 2.
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Table 1. Role of coffee in the modulation of oxidative stress biomarkers: overview of the acute human intervention studies.
Reference Subjects Type of Coffee and Composition Doses Study Design
Markers
Antioxidant
Capacity/Enzymes Lipid Damage
DNA
Damage
Protein
Damage
Agudelo-Ochoa
et al. [23]
74 healthy subjects
(38 males, 37 females),
mean age of 38.5 ˘ 6.9 years,
mean BMI 24.1 ˘ 2.6 kg/m2
Control group:
13 males, 12 females;
14 subjects aged 20–40 years,
11 aged 41–60 years
Group MCCGA:
12 males, 13 females; 14 subjects aged
20–40 years, 11 aged 41–60 years
Group HCCGA:
12 males, 12 females; 10 subjects aged
20–40 years, 14 aged 41–60 years
Coffee 1 (MCCGA):
Colombian Arabica coffee
Composition:
total CGAs 105 ˘ 4.1 mg/100 mL,
cafestol 0.19 ˘ 0.03 mg/100 mL,
kahweol 0.22 ˘ 0.03 mg/100 mL,
caffeine 47 ˘ 1.4 mg/100 mL
Coffee 2 (HCCGA):
Colombian Arabica coffee
Composition:
total CGAs 195 ˘ 6.9 mg/100 mL,
cafestol 0.19 ˘ 0.01 mg/100 mL,
kahweol 0.23 ˘ 0.02 mg/100 mL,
caffeine 49 ˘ 1 mg/100 mL
Coffee group 1:
400 mL of MCCGA coffee
Coffee group 2:
400 mL of HCCGA coffee
Control group:
no coffee
Parallel
intervention ÒAC (FRAP)
Teekachunhatean
et al. [24]
11 healthy men,
(mean age 21.09 ˘ 7.97 years,
mean BMI 20.80 ˘ 2.27 kg/m2)
Coffee 1:
Coffee enema, prepared mixing 4 g of ground
coffee beans with 100 mL of purified water.
Composition: n.d
Coffee 2:
Coffee for oral procedure: ready-to-drink
coffee beverage
Composition: n.d
Coffee group 1:
Coffee enema (500 mL)
Coffee group 2:
180 mL ready-to-drink coffee
Control group: n.d
Randomized,
two-phase,
crossover
intervention
=GSH
ÓTAC
=MDA
Bloomer et al. [25]
16 healthy subjects
(8 males, 8 females;
mean age 29.2 ˘ 14.4 years,
mean BMI 23.3 ˘ 2.2 kg/m2)
Coffee:
caffeinated and decaffeinate
Composition:
175 mg caffeine (caffeinated),
15 mg caffeine (decaffeinated) per 16 ounces
Coffee group 1:
16 ounces of freshly brewed
caffeinated coffee following milk
shake consumption
Coffee group 2:
16 ounces of freshly brewed
decaffeinated coffee following milk
shake consumption
Control group:
16 ounces of bottled water,
following milk shake consumption
Parallel
intervention =TAC =MDA
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Table 1. Cont.
Reference Subjects Type of Coffee and Composition Doses Study Design
Markers
Antioxidant
Capacity/Enzymes Lipid Damage
DNA
Damage
Protein
Damage
Leelarungrayub
et al. [26]
26 sedentary men
Group 1 (Caffeine):
10 males, mean age 20.5 ˘ 0.53 years,
mean BMI 22.84 ˘ 2.65 kg/m2
Group 2 (Decaffeinated):
10 males, mean age 20.3 ˘ 0.48 years,
mean BMI 22.27 ˘ 3.56 kg/m2
Group 3 (Control):
6 males, mean age 20.17 ˘ 0.98 years,
mean BMI 23.06 ˘ 3.60 kg/m2
Coffee 1:
Caffeinated coffee
Composition: n.d.
Coffee 2:
Decaffeinated coffee (Instant freeze dried)
Composition: n.d.
Coffee group 1:
Caffeinated (5 mg caffeine/kg bw)
coffee followed by a submaximal
exercise test
Coffee group 2:
decaffeinated coffee followed by a
submaximal exercise test
Control group:
No coffee consumption followed
by a submaximal exercise test
Parallel
intervention =TAC ÒMDA
Moura-Nunes
et al. [27]
10 subject
(3 males and 7 females),
range age 22–57 years, BMI n.d.
Coffee:
Instant coffee 100% Arabica prepared
dissolving 8 g in 200 mL boiling water.
Composition: n.d.
Coffee group:
200 mL instant coffee beverage
Control group:
200 mL water
Randomized,
controlled,
crossover
intervention
ÒAC (TRAP
and FRAP)
Natella et al. [28] 10 healthy nonsmoker subjects(5 males, 5 females), age and BMI n.d.
Coffee:
Coffee Lavazza Qualità Rossa
Composition:
caffeine 181 ˘ 10 mg/cup, theobromine
28.9 ˘ 1.1 mg/cup, total phenols 161 ˘ 9 mg
of GAE/cup, TRAP 10.1 ˘ 0.6 mM
ROO¨ eq./cup
Tea:
Twining Earl Gray
Composition:
caffeine 130 ˘ 7 mg/cup,
theobromine 5.9 ˘ 0.4 mg/cup,
total phenols 87 ˘ 9 mg of GAE/cup,
TRAP 1.3 ˘ 0.1 mM ROO¨ equiv/cup
Coffee group:
200 mL of brewed coffee
Control group:
200 mL of Twining Earl Gray tea
Baseline and
post-intervention
ÒAC (TRAP)
ÒSH groups (ns)
Ochiai et al. [29]
14 healthy men,
(mean age 36.2 ˘ 7.8 years,
mean BMI 22.7 ˘ 1.8 kg/m2)
Coffee:
Coffee polyphenol (CPP) prepared from green
coffee beans by
hot water extraction
Composition:
Total CQA content 80.7%
Coffee group:
CPP (600 mg CGAs,
co-administered with the
glucose solution)
Control group:
225 mL of a 75-g Glu-equivalent
test solution
Single-blind,
randomized,
controlled,
crossover
intervention
ÒMDA
(no differences
among treatment)
ÒIsoPs
(no differences
among treatment)
Molecules 2016, 21, 979 7 of 20
Table 1. Cont.
Reference Subjects Type of Coffee and Composition Doses Study Design
Markers
Antioxidant
Capacity/Enzymes Lipid Damage
DNA
Damage
Protein
Damage
Ochiai et al. [30]
13 healthy men,
(mean age 44.9 ˘ 1.4 years,
mean BMI 21.9 ˘ 0.6 kg/m2)
Coffee:
Coffee bean polyphenol (CBP) beverage
Composition:
600 mg CGA/100 mL water
Coffee group:
600 mg CGAs (equivalent to
two cups of coffee) in
100 mL of water after a test meal
Control group:
100 mL of water after a test meal
Double-blind,
randomized,
crossover
intervention
ÒMDA
(no differences
among treatment)
ÓIsoPs
Sirota et al. [31]
10 healthy subjects
Characteristics of the subjects: n.d.
Coffee 1:
Turkish roasted ground coffee (A)
Composition:
110 mg polyphenols/g¨dm
Coffee 2:
Turkish roasted ground coffee (AG) enriched
by 2% freeze-dried powder of green beans
Composition:
123 mg polyphenols/g¨dm
200 mL coffee A,
AG or water together with
250 g red-meat cutlets
Crossover
intervention
ÓMDA
concentration
ÓMDA absorption
after coffee A, less
after coffee AG
Mursu et al. [32]
45 nonsmoking volunteer men
(mean age, 26 ˘ 6 years and
BMI < 32 kg/m2). Only 35 subjects
completed the trial
Coffee:
Finely ground coffee, repared by filtering
through paper (7–8 g of grounds per one
150-mL cup)
Composition:
80.9 ˘ 3.3 mg/100 mL of phenolic acids, with
CGA as major compound (~90%)
Coffee group:
1–2 cups (150–300 mL,
respectively)
Control group: No coffee
Parallel
intervention
=LDL-conjugated
dienes
=Plasma hydroxy
fatty acids
=F2-IsoPs
Bakuradze
et al. [33]
13 healthy men subjects
(mean age 23 ˘ 2.4 years,
mean BMI 23.8 ˘ 1.6 kg/m2)
Arabica coffee, freshly prepared in a
pad machine
Composition:
16.7 ˘ 0.7 mg/g caffeine,
10.4 ˘ 0.9 mg/g CGA,
1.1 ˘ 0.2 NMP and
3.9 ˘ 0.3 mg/g trigonelline
Coffee group:
200 mL
Control group: n.d
Baseline and
post
intervention
ÓSBs
AC: antioxidant capacity; BMI: body mass index; CGA: chlorogenic acids; FRAP: ferric-reducing antioxidant power; GAE: gallic acid equivalent; GSH: reduced glutathione;
IsoPs: isoprostanes; MDA: malondialdehyde; NMP: N-methylpyridinium; SBs: strand breaks; TAC: total antioxidant capacity; TRAP: total reactive antioxidant potential.
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Table 2. Role of coffee in the modulation of oxidative stress biomarkers: overview of the long-term human intervention studies.
Reference Subjects Type of Coffee and Composition Doses Study Design
Markers
Antioxidant
Capacity/Enzymes Lipid Damage DNA Damage
Protein
Damage
Agudelo-Ochoa
et al. [23]
74 healthy subjects
(38 males, 37 females),
mean age of 38.5 ˘ 6 9 years,
mean BMI 24.1 ˘ 2.6 kg/m2
Control group:
13 males, 12 females; 14 subjects aged
20–40 years, 11 aged 41–60 years
Group MCCGA:
12 males, 13 females; 14 subjects aged
20–40 years, 11 aged 41–60 years
Group HCCGA:
12 males, 12 females; 10 subjects aged
20–40 years, 14 aged 41–60 years
Coffee 1 (MCCGA):
Colombian Arabica coffee
Composition:
total CGAs 105 ˘ 4.1 mg/100 mL,
cafestol 0.19 ˘ 0.03 mg/100 mL,
kahweol 0.22 ˘ 0.03 mg/100 mL,
caffeine 47 ˘ 1.4 mg/100 mL
Coffee 2 (HCCGA):
Colombian Arabica coffee
Composition:
total CGAs 195 ˘ 6.9 mg/100 mL,
cafestol 0.19 ˘ 0.01 mg/100 mL,
kahweol 0.23 ˘ 0.02 mg/100 mL,
caffeine 49 ˘ 1 mg/100 mL
Coffee group 1:
400 mL/day of MCCGA
for 8 weeks
Coffee group 2:
400 mL/day of HCCGA
for 8 weeks
Control group:
no coffee for 8 weeks
Parallel
intervention ÓAC (FRAP)
Teekachunhatean
et al. [24]
11 healthy men,
mean age 21.09 ˘ 7.97 years,
mean BMI 20.80 ˘ 2.27 kg/m2
Coffee 1:
(Enema, coffee prepared mixing 4 g of
ground coffee beans with 100 mL of
purified water.
Composition: n.d.
Coffee 2:
coffee for oral procedure:
ready-to-drink coffee beverage
Composition: n.d.
Coffee group 1:
Coffee enema (500 mL,
3 times/week for 6 visits)
Coffee group 2:
180 mL ready-to-drink coffee
(2/day for 11 days)
Control group: n.d.
Randomized,
crossover
intervention
=GSH
ÓTEAC
=MDA
Mursu et al. [32]
45 nonsmoking men
(mean age, 26 ˘ 6 years
and BMI < 32 kg/m2).
43 subjects completed the trial
Coffee:
finely ground coffee, repared by filtering
through paper (7–8 g of grounds per one
150-mL cup)
Composition:
80.9 ˘ 3.3 mg/100 mL of phenolic acids,
with CGA as major compound (~90%)
Coffee group 1:
3 cups (450 mL/day) of coffee
for 3 weeks
Coffee group 2:
6 cups (900 mL/day) of coffee
for 3 weeks
Control group:
No coffee consumption
for 3 weeks
Parallel
intervention =GPx
=Serum
LDL-conjugated
dienes
=Plasma hydroxy
fatty acids
=F2-IsoPs
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Table 2. Cont.
Reference Subjects Type of Coffee and Composition Doses Study Design
Markers
Antioxidant
Capacity/Enzymes Lipid Damage DNA Damage
Protein
Damage
Corrêa et al. [34]
Twenty healthy subjects
(6 males, 14 females),
mean age 49 ˘ 9 years, BMI n.d.
Coffee 1:
MLR-Medium Light Roast
paper-filtered coffee.
15 g per one 150-mL cup
Composition:
total phenolic content 11.09 ˘ 0.29 mg
5-CQAE/mL, total CGAs 1.98 ˘ 0.02 mg
5-CQAE/mL, caffeine 1.54 ˘ 0.01 mg/mL
Coffee 2:
Medium Roast (MR) paper-filtered coffee.
15 g per one 150-mL cup.
Composition:
total phenolic content 10.53 ˘ 0.56 mg
5-CQAE/mL, total CGAs 1.24 ˘ 0.01 mg
5-CQAE/mL,
caffeine 1.63 ˘ 0.02 mg/mL
Coffee group 1:
150 mL MLR for 4 weeks
Coffee group 2:
150 mL MR for 4 weeks
Control group: n.d.
Randomized,
cross-over
intervention
ÒAC (TAS and
ORAC)
ÒGPx
ÒCAT
ÒSOD
=OxLDL
=IsoPs
Hoelzl et al. [35]
29 subjects
(13 males: mean age 25.2 ˘ 5.6 years,
mean BMI 23.0 ˘ 1.7 kg/m2;
16 females:
mean age 29.3 ˘ 10.9 years,
mean BMI 21.8 ˘ 2.4 kg/m2)
Coffee:
mix of 35% green and 65% roasted coffee
water extracts
Composition:
total CGA 8.91% dm
Coffee group:
800 mL coffee/day over 5 days
Control group:
800 mL water/day over 5 days
Randomized,
controlled,
crossover
intervention
=GSH
=TAC
Ó8-IsoPs
=OxLDL
=MDA
=EndoIII and FPG
sensitive sites
=H2O2-induced
DNA damage
Ó3NT
Misik et al. [36]
38 healthy nonsmokers subjects
(14 males, 24 females),
mean age 27.6 ˘ 8.0 years,
mean BMI 22.3 ˘ 2.8 kg/m2
Coffee:
coffee brand “Tchibo Beste Bohne” (100%
Arabica) prepared by paper filtration.
Composition:
total CGA 125 mg/100 mL,
caffeine 65 mg/100 mL
and NMP 3.1 mg/100 mL
Coffee group:
800 mL coffee/day over 5 days
Control group:
800 mL water/day over 5 days
Randomized,
controlled,
crossover
intervention
=SOD
=GPx
=GSH
=TAC
=IsoPs
=OxLDL
=MDA
ÓFPG-sensitive sites
ÓEndoIII sensitive
sites (ns)
=H2O2-induced
DNA damage
=3NT
Revuelta-Iniesta
& Al-Dujaili [37]
20 subjects
(7 males, 13 females),
mean BMI 24.23 ˘ 4.6 kg/m2,
age n.d.
Coffee 1:
BC (black coffee): Sainsbury’s Original
Blend Cafetière Coffee
Composition:
polyphenols ranging from 1451 mg
GAE/100 mL (Filter method) to
2475 mg GAE/100 mL
(French Cafetiere)
Coffee 2:
GC (green coffee): Ethiopian Harrar 4
(100% Arabica)
Composition:
polyphenols ranging from 972 mg
GAE/100 mL (French Cafetiere) to
2052 mg GAE/100 mL (Italian Cafetiere)
Coffee group 1:
40 g/day of GC for 2 weeks
Coffee group 2:
40 g/day of BC for 2 weeks
Control group: n.d.
Randomized,
cross-over
intervention
=AC (FRAP)
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Table 2. Cont.
Reference Subjects Type of Coffee and Composition Doses Study Design
Markers
Antioxidant
Capacity/Enzymes Lipid Damage DNA Damage
Protein
Damage
Kotyczka
et al. [38]
30 healthy subjects, mean age
26 ˘ 1 years, mean BMI
23.2 ˘ 0.5 kg/m2
Coffee 1:
CBs 30 g of roast powder. Dark roast
coffee beverage (NMP-CB, 260 ˝C, 5 min)
Composition:
rich in NMP (785 µmol/L) and low in
CGA (523 µmol/L).
Coffee 2:
Light roast coffee beverage
(CGA-CB, 260 ˝C, 2 min)
Composition:
rich in CGA (4538 µmol/L) and low in
NMP (56 µmol/L)
Coffee group 1:
500 mL/day of light roast
coffee for 4 weeks
Coffee group 2:
500 mL/day of dark roast
coffee for 4 weeks
Control group: n.d.
Randomized,
longitudinally,
intervention
ÒSOD (CGA-CB)
ÓSOD
(NMP-CB)
ÒCAT
ÒGPx (CGA-CB)
ÓGPx (NMP-CB)
ÒtGSH
(CGA-CB)
ÒtGSH
(NMP-CB)
Steinkellner
et al. [39]
First trial:
10 healthy nonsmokers subjects
(3 males, 7 females),
mean age 26 ˘ 4 years,
mean bw 75 ˘ 9 kg
Second trial:
14 subjects,
mean age 25 ˘ 6 years,
mean bw 74 ˘ 10 kg
Third trial:
subjects (number n.d.),
mean age 26 ˘ 6 years,
mean bw 72 ˘ 8 kg
Coffee 1:
unfiltered coffee: Ground coffee (“Brasil
sanft”) boiled in 10.0 L tap water for 5 min
and pressed through a metal mesh
Composition: n.d.
Coffee 2:
filtered coffee
Composition: n.d.
First trial:
Coffee group:
7 cups/day (in total 1 L) of
unfiltered coffee over 5 days
Control group: n.d.
Second trial:
Coffee group 1:
7 cups/day (in total 1 L) of
unfiltered coffee for 3 days
Coffee group 2:
7 cups/day (in total 1 L) of
filtered coffee for 3 days
Control group: n.d.
Third trial:
Coffee group:
7 cups/day (in total 1 L) of
unfiltered coffee for 5 days
Control group: n.d.
First trial:
Baseline and
post-intervention
Second trial:
Parallel
intervention
Third trial:
Baseline and
post-intervention
=GST in saliva
ÒGST in plasma
ÓBPDE-induced
DNA damage
Bakuradze
et al. [40]
33 healthy males
(range age 20–44 years;
mean BMI 25.6 ˘ 3.7 kg/m2)
Coffee:
special roasted and blended Arabica
coffee rich in both green and roast bean
constituents, especially in CGA and NMP
Composition:
72 mg/L NMP, 263.6 mg/L trigonelline,
720 mg/L caffeine
Coffee group:
750 mL/day (in three equal
portions) for 4 weeks
Control group:
750 mL/day water for 4 weeks
Randomized,
controlled,
cross-over
intervention
ÒGSH
=GSSG
ÒGSR activity
ÓSBs
ÓFPG-sensitive sites
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Table 2. Cont.
Reference Subjects Type of Coffee and Composition Doses Study Design
Markers
Antioxidant
Capacity/Enzymes Lipid Damage DNA Damage
Protein
Damage
Esposito
et al. [41]
23 healthy subjects
(18 treated and 5 controls),
smokers and non smokers
Coffee group:
7 males, 11 females;
age range 19–25 years,
mean BMI M 24.7 ˘ 2.9 kg/m2,
F 22.8 ˘ 5.4 kg/m2
Control group:
2 males, 3 females;
age range 20–27 years,
mean BMI males 23.0 ˘ 1.9 kg/m2,
females 22 ˘ 2.4 kg/m2;
Coffee:
5.1 ˘ 0.4 cups/day.
3.6 cups/day moka,
1.5 cups/day espresso;
moka 40–50 mL/cup,
espresso 25–35 mL/cup.
Decaffeinated coffee intake was 24% of
the total.
Composition: n.d.
Coffee group:
5 cups coffee/day for 1 week
Control group:
No coffee consumption for
1 week
Parallel
intervention ÒGSH
Grubben
et al. [42]
64 subjects
(31 males and 33 females;
mean age 43 ˘ 11 years,
mean BMI 24.5 ˘ 0.5 kg/m2)
Coffee:
blend of arabica and robusta beans.
39 g of ground coffee into a 1 L cafetière
coffee-pot
(1 L equals six cups)
Composition:
cafestol mean 34 ˘ 3 mg/L,
kahweol mean 26 ˘ 1 mg/L
Coffee group:
1 L/day of unfiltered cafetière
coffee for 2 weeks
Control group:
water, milk, tea chocolate drink
or broth for 2 weeks
Randomized,
controlled,
crossover
intervention
ÒGSH
(Colorectal
mucosa and
plasma)
Kempf et al. [43]
47 subjects
(11 males, 36 females),
mean age 54.0 ˘ 9.0 years,
mean BMI 29.2 ˘ 4.6 kg/m2
Coffee:
Juhla Mokka branded coffee,
made with participants’ coffee machines
at home
Composition: n.d.
Coffee group 1:
4 cups (150 mL per cup) of
coffee for 4 weeks
Coffee group 2:
8 cups (150 mL per cup) of
coffee for 4 weeks
Control group: n.d.
Single blind,
three stages
intervention
ÓIsoPs =3NT
Yukawa
et al. [44]
11 healthy men,
range age 21–31 years
Coffee:
coffee freshly prepared by mixing 8 g of
Arabica coffee with 150 mL water
Composition: n.d.
Coffee group:
150 mL coffee
(3 times per day for 1 week)
Control group:
mineral water for 1 week
(amount not reported)
Baseline and
post
intervention
ÓSusceptibility of
LDL to oxidation
ÓMDA
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Table 2. Cont.
Reference Subjects Type of Coffee and Composition Doses Study Design
Markers
Antioxidant
Capacity/Enzymes Lipid Damage DNA Damage
Protein
Damage
Bakuradze
et al. [45]
84 healthy subjects,
mean age 25.6 ˘ 5.8 years,
mean BMI 22.9 ˘ 1.9 kg/m2
Coffee 1:
blend (SB) coffee: 100% Arabica
Composition:
12.39 ˘ 0.1 mg/g caffeine,
19.31 ˘ 0.3 mg/g CGA, 0.39 ˘ 0.0 mg/g
NMP and 6.27 ˘ 0.1 mg/g trigonelline
Coffee 2:
market blend (MB) coffee, obtained from
equal portions of 4 Arabica and 1 Robusta
commercially available regular
coffee brands
Composition:
12.8 ˘ 0.2 mg/g caffeine,
10.01 ˘ 0.3 mg/g CGA,
1.20 ˘ 0.0 NMP and
3.42 ˘ 0.2 mg/g trigonelline
Coffee group:
750 mL/day of MB or SB
for 4 weeks
Control group: n.d.
Randomized,
non-controlled,
cross-over
intervention
ÓSBs
ÓFPG-sensitive sites
Bakuradze
et al. [46]
84 healthy men, range age 19–50 years,
mean bw 80.9 ˘ 12.4 kg
Coffee group: 42 men, mean BMI
24.9 ˘ 3.0 kg/m2
Control group: 42 men, mean BMI
24.4 ˘ 3.5 kg/m2
Coffee:
Arabica coffee, freshly prepared in a
pad machine
Composition:
11.78 ˘ 0.42 mg/g caffeine,
10.18 ˘ 0.33 mg/g CGA,
1.10 ˘ 0.05 NMP and
3.82 ˘ 0.09 mg/g trigonelline
Coffee group:
750 mL/day of coffee for
4 weeks
Control group:
750 mL/day of water for
4 weeks
Randomized,
controlled,
cross-over
intervention
ÓSBs
Bichler et al. [47] 8 healthy non-smokers volunteers(age range 20–50 years, BMI n.d.)
Coffee:
metal filtered coffee andpaper filtered
coffee, both prepared with 50 g of ground
coffee per liter
Composition: n.d.
Coffee group:
600 mL coffee/day (200 mL
metal filtered coffee and
400 mL paper filtered coffee)
for 5 days
Control group:
No coffee consumption
=GPx
ÓEndo and
FPG-sensitive sites
ÓH2O2- and
Trp-P-2-induced
DNA damage
Cardin et al. [48]
37 patients with chronic hepatitis C
(29 males, 8 females), mean age
58 ˘ 11 years, mean BMI
26 ˘ 5 kg/m2
Coffee:
100% Coffee Arabica prepared with an
Italian-style coffee machine
Composition: n.d.
Coffee group:
4 cups of coffee/day for
30 days
Control group:
no coffee consumption
for 4 weeks
Randomized,
controlled,
cross-over
intervention
Ó8-OHdG
Legend: 8-OHdG: 8-Hydroxydeoxyguanosine; AC: antioxidant capacity; BMI: body mass index; BPDE: (˘)-anti-B[a]P-7,8-dihydrodiol-9,10-epoxide; bw: body weight;
CAT: catalase; CGA: chlorogenic acids; ENDO III: endonuclease; FPG: formamidopyrimidine DNA glycosylase; FRAP: ferric-reducing antioxidant power; GAE: gallic acid
equivalent; GPx: glutathione peroxidase; GSH: reduced glutathione; GSR: glutathione reductase; GSSG: oxidized glutathione; IsoPs: isoprostanes; MDA: malondialdehyde;
NMP: N-methylpyridinium; NT: nytrotyrosine; ORAC: Oxygen radical absorbance capacity; OxLDL: oxidized LDL; SBs: strand breaks; SOD: superoxide dismutase;
TAC: total antioxidant capacity; TAS: total antioxidant status; TEAC: total equivalent antioxidant capacity.
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Three out of the 26 studies investigated the effects of both acute and chronic interventions with
coffee, while 8 were only acute studies (i.e., single dose), and 15 were chronic (medium-long term)
dietary intervention.
3. Results
3.1. Total Plasma Antioxidant Capacity and Antioxidant Enzymes
The effect of coffee consumption on the modulation of plasma antioxidant capacity was evaluated
in 10 of the selected studies. Two studies reported both acute and chronic interventions [23,24], four were
acute studies [25–28], while four were chronic intervention studies [34–37]. Three studies were not
placebo-controlled [24,34,37] and/or did not provide information about the bioactive composition
of coffee [24,26,27]. Total radical trapping antioxidant power (TRAP), Trolox-equivalent antioxidant
capacity (TEAC), total antioxidant status (TAS) and oxygen radical absorbance capacity (ORAC)
emerged as the most used methods. They differ from each other in terms of reaction mechanisms,
oxidant and target/probe species, reaction conditions and expression of the obtained results.
Only four (three acute and one chronic intervention) out of 10 studies reported a significant
increase in total plasma antioxidant capacity following coffee consumption. In particular, Moura-Nunes and
colleagues documented that a single serving of 200 mL of coffee increased plasma antioxidant
capacity, determined through FRAP and TRAP assays, by 2.6% and 7.6%, respectively, in a group
of healthy subjects [27]. Natella and coworkers observed an increase in plasma antioxidant capacity
(measured as TRAP) and thiol (SH) groups after consumption of 200 mL of coffee, which was even
more pronounced than that observed with the same amount of tea (+6% versus +4%, respectively) [28].
Agudelo-Ochoa et al. [23] reported that a single serving of 400 mL of coffee, providing either 420 mg
or 780 mg of chlorogenic acid, significantly increased plasma antioxidant capacity (+6% and +5%,
respectively) in a group of healthy volunteers, but these effects were lost following a long term
intervention. Finally, Corrêa et al. [34] reported that a 4-week intake of 150 mL/day of medium
light roast (MLR) or medium roast (MR) paper-filtered coffee increased the levels of TAS by about
21% and 26% respectively, while ORAC increased only after the consumption of medium light roast
paper-filtered coffee. The lack of homogeneous results could be due to differences in the duration of
the intervention, the type and the amount of coffee provided, the composition in bioactive compounds,
and the method used for the determination of antioxidant capacity.
The effect of coffee in the modulation of endogenous antioxidant enzymes has been assessed
in seven chronic intervention trials. The duration of the studies varied from 1 to 4 weeks.
Superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase
(GSR) and glutathione S-transferases (GSTs) were the most widely studied enzymes.
Overall, the results obtained are conflicting and do not provide evidence about the role of coffee
in the modulation of antioxidant enzymes. For example, Corrêa et al. [34] reported an increase in
erythrocyte antioxidant enzyme activity in healthy subjects following a 4-week intervention with
150 mL/day of MLR and MR paper-filtered coffee. In particular, SOD activity increased by 52% and
75% in MLR and MR group, while GPx activity by 62% and 49%, respectively. Moreover, both the
interventions significantly increased CAT activity by about 13%. Kotyczka et al. [38] documented that
a 4-week intake of light dark roasted coffee (rich in chlorogenic acid) resulted in increased erythrocyte
activities of SOD, GPx and CAT by 12%, 25% and 22%, respectively. On the contrary, the intake of
dark roasted coffee (poor in chlorogenic acid) decreased erythrocytes SOD and GPx activity by 5.8%
and 15%, respectively. Misik and colleagues showed that a 5-day coffee intake (800 mL/day) did
not significantly affect SOD and GPx activity in the cytosolic fractions of the lymphocytes of healthy
volunteers [36].
The activity of GST and GSR was evaluated in two studies. Steinkellner and colleagues reported
that a 5-day intervention with 1 L unfiltered coffee/day increased GST activity in plasma, but not in
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saliva, in a group of healthy individuals [39]. Bakuradze et al. [40] showed a significant increase in
GSR blood level activity following 4-week consumption of 750 mL/day of freshly brewed coffee.
Eight studies (seven chronic interventions and one acute trial) also investigated the role
of coffee in the modulation of blood glutathione (GSH) levels as a substrate of GPx and GST
enzymes. Four out of seven chronic intervention studies documented an increase in GSH
levels [38,40–42], while two long-term studies [35,36] and one study performing both an acute and a
chronic intervention [24] did not show any significant effect. Misik and coworkers attributed the lack
of effects to the degradation and metabolic conversion of different coffee constituents in the body [36],
while for Teekachunhatean and colleagues the short duration of the intervention could be at least
partially responsible for the absence of a relevant effect [24].
3.2. Protein Damage
The effect exerted by coffee intake on protein damage has been investigated only in three
studies [35,36,43]. Those studies differed for the fed coffee type, which was instant coffee [35],
coffee homemade with participants’ coffee machines [36] or coffee prepared by paper filtration [43].
In two studies [35,43], partially performed by the same research group, a controlled intervention trial
with a cross-over design was scheduled, where subjects were randomized to consume coffee or a
control drink (water) for periods of 5 days each, spaced out by a washout phase and dietary restriction.
Differently, Kempf and coworkers investigated the effect of two different doses of coffee (4 and 8 cups,
corresponding to 600 and 1200 mL respectively) by using a simple experimental design: subjects had
to follow 4 weeks of restrictive diet, followed by 4 weeks with 4 cups coffee/day and 4 weeks of
8 cups coffee/day [43]. The studies performed by Hoelzl et al. [35] and Misik et al. [36] were also
similar for what concerns the volunteers, being nonsmokers and normal weight young adults in both
cases, contrarily to the study by Kempf et al. [43] where subjects with a high risk of type 2 diabetes
were recruited. In all the three studies, the marker of protein damage was 3-nytrotirosine (3-NT),
a stable post-translational modification in proteins, deriving from the reaction of free or protein-bound
tyrosine with reactive nitrogen oxide species including peroxynitrite, nitrogen dioxide and nitrous
acid. 3-NT has been suggested to be associated with coronary heart disease (CAD) independently of
traditional risk factors [49]. The marker was monitored by LC-MS/MS in two studies [35,36] and by
an enzyme immunoassay in the third one [38]. A significant effect of coffee was found only by Hoelzl
and colleagues, who observed a significant decrease of 3-NT (16.1%) after 4-week coffee intake [35].
Despite many similarities between the investigations by Hoelzl et al. [35] and Misik et al. [36]
(i.e., duration of the intervention, amounts of CGA provided), the latter found no significant effect
after coffee intake, in line with the observations of Kempf and colleagues [43]. A possible explanation
for such different findings might be linked to the amount of coffee bioactives other than CGA provided
with the two different coffee brews. However, Hoelzl et al. [35] provided information only about CGA,
making a clear comparison between the two investigations practically impossible.
The small number of investigations about the possible role of coffee consumption on markers of
protein damage, together with the heterogeneity of the findings, calls for further studies focusing on
this aspect of oxidative damage to biomolecules.
3.3. Lipid Damage
The effect of coffee consumption on markers of lipid oxidation has been investigated in
12 studies [24–26,29–32,34–36,43,44]. Five out of 12 studies investigated only the acute effect of coffee
consumption [25,26,29–31], five were chronic intervention studies [34–36,43,44], while two studies
investigated both acute and chronic effects [24,32].
In these studies, isoprostanes (IsoPs) and malondialdehyde (MDA) were the most frequently
considered markers of lipid damage. In detail, isoprostanes are a class of end-products of peroxidation
of arachidonic acid, which are collectively referred as F2-IsoPS due to their similarity to prostaglandin
F2α. Among them, 8-isoprostaglandin F2α (8-Iso PGF2α) is commonly used for evaluating oxidative
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stress, through both chromatographic techniques and immunoassays. MDA is instead a three
carbon, low molecular weight aldehyde representing the main product of polyunsaturated fatty
acid peroxidation. It is characterized by a high toxicity due to its ability to react with other molecules
like DNA and protein [50]. In all the studies evaluating MDA, the reaction with 2-thiobarbituric
acid (TBA) was used, so results were reported as TBA reacting substances (TBARS) instead of MDA.
In spite of the risk of overestimation of MDA, the TBARS method represents the most common test for
evaluating lipid peroxidation.
Besides 8-IsoPGF2 and MDA, further markers of lipid damage and/or protection considered in
the present review were oxidized LDL, resistance to LDL oxidation, serum LDL-conjugated dienes and
hydroxyl fatty acids. The analysis of the main findings revealed that most of the interventions failed
to demonstrate a significant decrease in markers of lipid damage with exception of results found by
Ochiai et al. [30] and Sirota et al. [31]. The former reported a significantly reduced urinary 8-epiPGF2α
following consumption of a coffee beverage (providing 600 mg of CGAs) when compared with placebo
in healthy men. Results showed that consumption of 200 mL Turkish roasted coffee during a meal based
on red-meat cutlets resulted in a significant inhibition of postprandial plasma MDA. No effect between
treatments and control/placebo were instead found by other authors [25,29,32]. The investigation
by Leelarungrayub et al. [26] deserves a special mention, because it reports a significant higher level
of MDA in men consuming caffeinated coffee, when compared to decaffeinated coffee or control,
followed by a submaximal exercise test. Authors reported that, similarly to what observed in previous
investigations, results demonstrated an increased intramuscular fat oxidation following consumption
of caffeine-rich foods.
Among medium-long term intervention studies, a significant decrease in isoprostanes was
observed only in three studies [30,35,43], while no significant change was reported by Mursu et al. [32]
and Misik et al. [36]. Even if the exact composition of the coffee used has not been always provided,
the differences in the findings seem to be at least partially attributable to the different composition of
the brews.
For what concerns the other markers of lipid damage, only Yukawa et al. [44] found a modest
reduction of LDL oxidation susceptibility and a decrease of MDA levels following consumption of
3 coffees/day for 1 week. No significant effect was instead found by Mursu et al. [32] on serum
LDL-conjugated dienes and plasma hydroxyl fatty acids, or by Teekachunhatean et al. [24] on MDA
levels [24] and by Hoelzl et al. [35] on both MDA and oxidized LDL.
3.4. DNA Damage
The role of coffee on markers of DNA damage has been investigated in nine studies (eight chronic
interventions and one acute study), four of which performed by the same research group [33,40,46,47].
Eight out of nine studies measured the levels of DNA damage through the comet assay, a single cell
gel electrophoresis technique widely used also in human biomonitoring and dietary intervention
studies [51,52]. Three of these studies [33,46,47] investigated the effect of coffee on spontaneous
DNA strand breaks (SBs), which directly reflect the background DNA oxidative damage within
cells. Background SBs may derive from endogenous and/or exogenous exposure to DNA damaging
agents and/or may reflect incomplete DNA repair. The consumption of coffee was associated to
reduce DNA SBs in healthy volunteers. Bakuradze et al. [33] reported that the ingestion of 800 mL
of coffee (200 mL every 2 h) significantly reduced (up to 30%) DNA SBs in a short-term human
intervention study. The same research group documented that coffee consumption (3 ˆ 250 mL
per day) was associated with DNA-protective effects (p < 0.001) in a 4-week, double-blind, randomized,
crossover intervention [46]. Finally, the same authors showed that a daily consumption of 750 mL of
fresh dark roast coffee decreased by 27% spontaneous DNA SBs in a 4-week, randomized, controlled
trial [47].
Five out of eight studies investigated the effects of coffee consumption on oxidized DNA
bases through the exploitation of specific enzymes such as formamidopyrimidine-DNA glycosylase
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(FPG) and/or endonuclease III (Endo III), able to detect oxidized purines and pyrimidine bases,
respectively [53,54]. Some studies also evaluated the resistance to oxidatively induced DNA damage,
using H2O2 [35,36,48], BPDE [39] and Trp-P-2 [47] as oxidative agents.
Bichler and coworkers showed that the consumption of 600 mL coffee (400 mL paper filtered and
200 mL metal filtered/day) for 5 days reduced both endogenous (FPG and Endo III-sensitive sites by
64% and 48%, respectively) and oxidatively induced DNA damage (measured as DNA resistance to
H2O2 and Trp-P-2 by 17% and 35%, respectively) in a group of healthy volunteers [47]. Steinkellner
and colleagues documented that a 5-day intervention with 1 L unfiltered coffee/day increased cell
protection from (˘)-anti-B[a]P-7,8-dihydrodiol-9,10-epoxide oxidative insult in a group of healthy
subjects [39]. Misik et al. [36] reported a significant reduction in the levels of FPG (by 12.3%) and
Endo III-sensitive sites (by 10%), but not DNA resistance to H2O2-oxidative treatment, following the
administration for 5 days of 800 mL/day of paper filtered coffee. Hoelzl and colleagues showed that
the intake of a comparable amount of instant coffee co-extracted from green and roasted beans did not
significantly affect the levels of FPG and Endo III-sensitive sites, and H2O2-induced DNA damage,
in a group of healthy individuals [35].
Another marker widely used to measure oxidized base lesion is 8-oxo-21-deoxyguanosine
(8-OHdG), as, among all purine and pyridine bases, guanine is the most prone to oxidation and
a common biomarker reflecting the balance between oxidative damage and repair rate [55]. The role
of coffee in the modulation of 8-OH-dG was evaluated only in one study, with positive results [48].
The study was performed in a group of patients affected by chronic hepatitis C and the authors
documented that 8-OHdG levels were significantly lower during coffee intake (30-day consumption of
4 cups of coffee/day), with almost a three-fold decrease.
4. Conclusions
During the last five years, coffee has been the objective of several studies for its potential role
in human health, with a specific focus on the prevention of several chronic degenerative diseases.
The current review summarized the main findings of 26 studies performed in humans, with the aim
of comparing results on the effect of coffee consumption on the main markers of oxidative damage to
lipid, DNA and protein, as well as on the modulation of antioxidant capacity and antioxidant enzymes
in humans. Studies were performed on healthy subjects with the exception of one study in which
patients with chronic hepatitis C were recruited.
Overall, a high heterogeneity among studies was observed, mainly in terms of doses and duration
of the interventions, and, in several studies, information concerning the polyphenol content of the
coffee used was lacking. Only a few studies provided the content of CGAs, caffeine and other bioactive
compounds in the fed coffee brew, and, in general, they did not describe in great detail the way coffee
was prepared (i.e., grams of coffee used for each dose). This lack of information about the composition
of the brews makes the comparison among studies extremely difficult, with an objective evaluation of
a dose-response effect almost impossible. Therefore, the need for more detailed information about the
chemical composition of coffees in future studies appears crucial for a more accurate analysis of results.
Despite these complications, the main findings of the reviewed works seem to suggest that
consumption of coffee may increase glutathione levels and reduce the levels of DNA damage.
These effects are more evident in chronic interventions than in acute studies, letting hypothesize that a
long-term exposure to coffee and/or its bioactive compounds is needed to obtain such putative health
effects. On the contrary, an extreme heterogeneity of the results has been observed for total plasma
and serum antioxidant status, as well as for protein and lipid damage. This could be attributed to
the different biomarkers and methods used for their evaluation. Based on the difficulties described
above, a comprehensive understanding of the beneficial effects of coffee on oxidative stress markers,
through the development of robust and well-controlled intervention studies, is required.
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